Resmed CFO Brett Sandercock to Retire; Aaron Bloomer Named Successor
Resmed, a health technology company, announced the retirement of CFO Brett Sandercock effective May 4, 2026, after 27 years with the company. Aaron Bloomer, previously CFO at Exact Sciences, has been appointed as his successor. The transition follows a comprehensive search process, with the CEO praising Bloomer’s experience in driving growth and operational discipline. Sandercock will serve as an advisor through the end of 2027.
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced that Brett Sandercock, Chief Financial Officer, plans to retire effective May 4, 2026. After conducting a comprehensive search, Aaron Bloomer has been appointed as his successor.